Babak OY, Lapshyna KA. The fibroblasts growth factor 21 study in patients with non-alcoholic fatty liver disease and hypertension comorbidities. Zaporozhye medical journal [Internet]. 2020Apr.13 [cited 2024Apr.29];22(2). Available from: http://zmj.zsmu.edu.ua/article/view/200572